| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/EN.134.1.264 |
| P698 | PubMed publication ID | 8275942 |
| P50 | author | Gökhan Hotamışlıgil | Q6033455 |
| P2093 | author name string | Spiegelman BM | |
| Lorenz K | |||
| Hofmann C | |||
| Braithwaite SS | |||
| Colca JR | |||
| Palazuk BJ | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | preproinsulin | Q7240673 |
| insulin resistance | Q1053470 | ||
| P304 | page(s) | 264-270 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | Endocrinology | Q3054009 |
| P1476 | title | Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. | |
| P478 | volume | 134 |
| Q35683565 | 1. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands and their therapeutic utility |
| Q30440168 | Adiponectin activates adenosine monophosphate-activated protein kinase and decreases luteinizing hormone secretion in LbetaT2 gonadotropes |
| Q37400719 | Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. |
| Q33309488 | An extensive phenotypic characterization of the hTNFalpha transgenic mice |
| Q44881291 | Angiotensin-converting enzyme inhibition, body composition, and physical performance in aged rats |
| Q34441030 | Anti diabetic effect of CL 316,243 (a β3-adrenergic agonist) by down regulation of tumour necrosis factor (TNF-α) expression |
| Q33600223 | Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARγ-driven enhancers |
| Q35669787 | Caloric restriction, body fat and ageing in experimental models |
| Q35484864 | Ceramides as modulators of cellular and whole-body metabolism |
| Q46013208 | Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats. |
| Q33954537 | Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology |
| Q58696993 | Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead Compounds |
| Q34359953 | Diet and lifestyle factors modify immune/inflammation response genes to alter breast cancer risk and prognosis: the Breast Cancer Health Disparities Study |
| Q45009685 | Diet but not aerobic exercise training reduces skeletal muscle TNF-alpha in overweight humans |
| Q47573448 | Diet-induced obesity alters immune cell infiltration and expression of inflammatory cytokine genes in mouse ovarian and peri-ovarian adipose depot tissues. |
| Q41148387 | Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons |
| Q42158524 | Down-regulation of cyclic-nucleotide phosphodiesterase 3B in 3T3-L1 adipocytes induced by tumour necrosis factor alpha and cAMP |
| Q35158545 | Effect of Lactobacillus plantarum Strain K21 on High-Fat Diet-Fed Obese Mice |
| Q33612248 | Effects of Low-Molecular-Weight Fucoidan and High Stability Fucoxanthin on Glucose Homeostasis, Lipid Metabolism, and Liver Function in a Mouse Model of Type II Diabetes |
| Q33818388 | Effects of long-term pioglitazone treatment on peripheral and central markers of aging |
| Q51484986 | Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus. |
| Q35214910 | Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice |
| Q51563832 | Elevated serum TNF-alpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients. |
| Q47267166 | Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome |
| Q36271804 | Endocrine and metabolic changes in human aging |
| Q46758003 | Energy restriction enhances therapeutic efficacy of the PPARgamma agonist, rosiglitazone, through regulation of visceral fat gene expression |
| Q49402354 | Evaluation of TNF-α and IL-6 mRNAs expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol |
| Q44019556 | Exercise training increases membrane bound form of tumor necrosis factor-alpha receptors with decreases in the secretion of soluble forms of receptors in rat adipocytes |
| Q40640603 | Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinoma: correlation with histological type and grade |
| Q42470748 | Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-alpha? |
| Q42676214 | IRS1, KCNJ11, PPARgamma2 and HNF-1alpha: do amino acid polymorphisms in these candidate genes support a shared aetiology between type 1 and type 2 diabetes? |
| Q42679811 | Immunofluorescent localisation of tumour necrosis factor-alpha receptors on the popliteal lymph node and the surrounding adipose tissue following a simulated immune challenge |
| Q38352272 | Impact of dietary FA and energy restriction on plasma leptin and ob gene expression in mice. |
| Q28586493 | Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle |
| Q29012156 | Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance |
| Q35676828 | Insulin as an anti-inflammatory and antiatherosclerotic hormone |
| Q44826390 | Insulin resistance and changes in plasma concentration of TNFalpha, IGF1, and NEFA in dogs during weight gain and obesity |
| Q43721032 | Insulin resistance induced in dairy steers by tumor necrosis factor alpha is partially reversed by 2,4-thiazolidinedione |
| Q34962291 | Insulin resistance, diabetes, and atherosclerosis: thiazolidinediones as therapeutic interventions |
| Q54105933 | Insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment: current status and therapeutic possibilities. |
| Q33936964 | Interaction between aging and syndrome X: new insights on the pathophysiology of fat distribution |
| Q35788915 | Intramyocellular lipids and insulin resistance |
| Q73635302 | KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-alpha production |
| Q41284427 | Lessons from animal models of obesity |
| Q35087481 | Lipid abnormalities in the metabolic syndrome |
| Q33632888 | Mechanisms by which Thiazolidinediones Enhance Insulin Action |
| Q34716953 | Metabolic and additional vascular effects of thiazolidinediones. |
| Q34877856 | Metabolic effects of obesity: A review |
| Q35070980 | MicroRNA-494, upregulated by tumor necrosis factor-α, desensitizes insulin effect in C2C12 muscle cells |
| Q38598170 | Modulating the Genomic Programming of Adipocytes. |
| Q37692841 | Nuclear receptors and metabolism: from feast to famine |
| Q27000398 | Obesity and adipokines: effects on sympathetic overactivity |
| Q37383968 | Obesity and diabetes in TNF-alpha receptor- deficient mice |
| Q92923659 | Omega-3 Versus Omega-6 Polyunsaturated Fatty Acids in the Prevention and Treatment of Inflammatory Skin Diseases |
| Q42824513 | Opposing effects of tumour necrosis factor alpha and hyperosmolarity on Na+/myo-inositol co-transporter mRNA levels and myo-inositol accumulation by 3T3-L1 adipocytes. |
| Q40967479 | Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-alpha |
| Q26863678 | PPAR-γ -- a possible drug target for complicated pregnancies |
| Q37407887 | PPARγ signaling and metabolism: the good, the bad and the future |
| Q41785033 | Peroxisome Proliferator-Activated Receptor Gamma Exacerbates Concanavalin A-Induced Liver Injury via Suppressing the Translocation of NF-κB into the Nucleus |
| Q34236636 | Peroxisome proliferator-activated receptor (PPAR) gamma agonists for diabetes |
| Q44786921 | Peroxisome proliferator-activated receptor beta/delta regulates very low density lipoprotein production and catabolism in mice on a Western diet. |
| Q36812788 | Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives |
| Q38323080 | Pharmacological profile of a novel, non-TZD PPARgamma agonist |
| Q41767005 | Pioglitazone alters monocyte populations and stimulates recent thymic emigrants in the BBDZR/Wor type 2 diabetes rat model |
| Q46982956 | Pioglitazone. Review of its metabolic and systemic effects |
| Q52738986 | Podocan Is Expressed in Blood and Adipose Tissue and Correlates Negatively With the Induction of Diabetic Nephropathy. |
| Q33957444 | Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes |
| Q36795404 | Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer |
| Q35617479 | Progressive obesity alters ovarian folliculogenesis with impacts on pro-inflammatory and steroidogenic signaling in female mice. |
| Q33568689 | Proinflammatory cytokines differentially regulate adipocyte mitochondrial metabolism, oxidative stress, and dynamics |
| Q34190131 | Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha |
| Q37051264 | Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease. |
| Q37377746 | Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus |
| Q38132175 | Sphingolipid metabolic pathway: an overview of major roles played in human diseases |
| Q35134231 | Surgical removal of visceral adipose tissue: effects on insulin action |
| Q40857239 | TNF-alpha and insulin resistance: summary and future prospects |
| Q44445405 | TNF‐α polymorphisms and type 2 diabetes mellitus in Taiwanese patients |
| Q26771455 | The Macrophage Switch in Obesity Development |
| Q54988933 | The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis. |
| Q45272329 | The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats. |
| Q34216687 | The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase |
| Q35774924 | The role of TNF-alpha in insulin resistance |
| Q36404490 | The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity |
| Q36984669 | The role of exercise and PGC1alpha in inflammation and chronic disease |
| Q37373072 | Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling |
| Q35162317 | Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence |
| Q74485015 | Transcriptional control of adipogenesis |
| Q28379378 | Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats |
| Q77493171 | Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse |
| Q44346176 | Tumor Necrosis Factor Alpha Promoter Polymorphism in Posttransplantation Diabetes Mellitus of Renal Transplant Recipients |
| Q42828385 | Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2. |
| Q35304189 | Tumor necrosis factor alpha inhibits signaling from the insulin receptor |
| Q36385275 | Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1 |
| Q35175151 | Tumor necrosis factor alpha mediates apoptosis of brown adipocytes and defective brown adipocyte function in obesity |
| Q37831189 | Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies |
| Q37375694 | Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes |
| Q33827934 | Tumor necrosis factor-alpha-induced insulin resistance in adipocytes |
| Q35625835 | Tumor necrosis factor-related genes and colon and rectal cancer. |
Search more.